首页> 外文期刊>British Journal of Cancer >Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis
【24h】

Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis

机译:大肠癌中HLA-DR的高表达与良好的预后相关

获取原文
获取外文期刊封面目录资料

摘要

One hundred large bowel carcinomas operated on between 1978 and 1982 were studied immunohistochemically with regard to expression of HLA-DR antigens. Three sections from each tumour were investigated by a semiquantitative scoring system, and a mean score for each patient established. Based on this scoring system, the tumours were divided into three groups: 0; 0.1-1.0; and > 1.0. All patients were followed until death (n = 68) or until June 1, 1992, and all cancer-specific deaths (n = 56) have been recorded. Analysis of survival in the whole patient group showed significant difference between the three levels of tumour HLA-DR expression (P = 0.006); patients who had tumours with strong HLA-DR expression showing the best survival. In a stratified analysis after Dukes' stages there was still a significant difference (P > 0.001) between the three levels of HLA-DR staining intensity. After a multiple regression analysis (Cox) with correction for different variables, the HLA-DR expression maintained its significance as a risk factor. To our knowledge this is the first time a relationship between intensity of tumour DR expression and survival has been shown in large bowel carcinoma.
机译:就HLA-DR抗原的表达进行了免疫组化研究,研究了1978年至1982年间手术的100例大肠癌。通过半定量评分系统研究每个肿瘤的三个切片,并确定每个患者的平均评分。基于该评分系统,将肿瘤分为三组:0;肿瘤;肿瘤;和肿瘤。 0.1-1.0;和> 1.0。跟踪所有患者直至死亡(n = 68)或直到1992年6月1日,并记录了所有癌症特异性死亡(n = 56)。整个患者组的生存分析显示,肿瘤HLA-DR表达的三个水平之间存在显着差异(P = 0.006); HLA-DR表达高的肿瘤患者生存率最高。在Dukes阶段之后的分层分析中,三种水平的HLA-DR染色强度之间仍然存在显着差异(P> 0.001)。在对不同变量进行校正的多元回归分析(Cox)之后,HLA-DR表达保持了其作为危险因素的重要性。据我们所知,这是大肠癌中首次显示出肿瘤DR表达强度与生存之间的关系。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号